Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Anne Lesur"'
Autor:
David Malka, Nicolas Girard, David M. Smadja, Christine Chevreau, Stéphane Culine, Anne Lesur, Roman Rouzier, François Rozet, Jean-Philippe Spano, Jean-Yves Blay
Publikováno v:
Bulletin du Cancer. 110:212-224
Autor:
David, Malka, Nicolas, Girard, David M, Smadja, Christine, Chevreau, Stéphane, Culine, Anne, Lesur, Roman, Rouzier, François, Rozet, Jean-Philippe, Spano, Jean-Yves, Blay
Publikováno v:
Bulletin du cancer.
Cancer-associated thrombosis (CAT) is a common complication resulting from various vascular mechanisms related to cancer, antitumoral therapy and patient status, and is associated with a poor prognosis. Anticoagulants recommended for CAT treatment or
Publikováno v:
Bulletin du Cancer. 106:S28-S36
Adjuvant endocrine therapy is highly effective and appropriate for all breast cancer patients with hormone receptor positive tumors, pre and post menopausal women. It's an oral daily pill for many years, after primary treatment. Although this medicat
Autor:
Julia Salleron, Anne Lesur, Georges Weryha, Sara El Hamdaoui, Marchal Frederic, Perle Sebaoun
Publikováno v:
Bulletin du Cancer. 106:S75-S100
Resume Introduction : Objectifs : Evaluer la tolerance du Tamoxifene (TAM) en termes d’effets secondaires et statut hormonal, la persistance du traitement sur cinq ans et rapporter les donnees du suivi lointain. Methodes : La population etudiee a i
Publikováno v:
Bulletin du Cancer. 106:S60-S74
Resume Introduction : Le cancer du sein de la femme jeune engendre des enjeux medico-psychologiques, notamment dans la perspective de l’« apres-cancer ». L’objectif de l’etude etait d’analyser les changements de prise en charge, a une decen
Autor:
Anne Lesur, Mahasti Saghatchian
Publikováno v:
Bulletin du Cancer. 106:S37-S42
Despite proven survival benefits after breast cancer, long-trem compliance with adjuvant hormone therapy remains a major issue, partly due to the side effects of treatment. In young women treated for breast cancer, these treatments include tamoxifen,
Autor:
Anne Lesur, Mahasti Saghatchian
Publikováno v:
Bulletin du Cancer. 106:S1-S3
Autor:
Mahasti, Saghatchian, Anne, Lesur
Publikováno v:
Bulletin du cancer. 106(12S1)
Despite proven survival benefits after breast cancer, long-trem compliance with adjuvant hormone therapy remains a major issue, partly due to the side effects of treatment. In young women treated for breast cancer, these treatments include tamoxifen,
Publikováno v:
Bulletin du cancer. 106(12S1)
Adjuvant endocrine therapy is highly effective and appropriate for all breast cancer patients with hormone receptor positive tumors, pre and post menopausal women. It's an oral daily pill for many years, after primary treatment. Although this medicat
Publikováno v:
Bulletin du cancer. 106(12S1)
Breast cancer of young women has medico-psychological issues, particularly in the perspective of "after cancer" period. The objective of the study was to analyze the changes in management, in a decade including the publication of Cancer Plans I and I